Selected genetic lesions may induce the expression of specific surface antigens (e.g., CD93 on MLL-r AML LSC [82]), which may hold great promise, however, currently remains exceptional and only applicable to rare AML subtypes. Here, CD93 is linked to acute myeloid leukemia.